skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Refined by: language: Russian remove subject: Treatment Outcome remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Material Type:
Article
Add to My Research

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

The Lancet (British edition), 2011, Vol.377 (9767), p.721-731 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 26-Mar 4, 2011 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)61354-2 ;PMID: 21296403 ;CODEN: LANCAO

Full text available

2
Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial
Material Type:
Article
Add to My Research

Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial

Journal of clinical oncology, 2013-10, Vol.31 (30), p.3791-3799 [Peer Reviewed Journal]

2014 INIST-CNRS ;2013 by American Society of Clinical Oncology 2013 ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2012.47.4940 ;PMID: 24019545

Full text available

3
Persistent Overall Survival Benefit and No Increased Risk of Second Malignancies With Bortezomib-Melphalan-Prednisone Versus Melphalan-Prednisone in Patients With Previously Untreated Multiple Myeloma
Material Type:
Article
Add to My Research

Persistent Overall Survival Benefit and No Increased Risk of Second Malignancies With Bortezomib-Melphalan-Prednisone Versus Melphalan-Prednisone in Patients With Previously Untreated Multiple Myeloma

Journal of clinical oncology, 2013-02, Vol.31 (4), p.448-455 [Peer Reviewed Journal]

2014 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2012.41.6180 ;PMID: 23233713

Full text available

4
Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group
Material Type:
Article
Add to My Research

Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group

Journal of clinical oncology, 2013-02, Vol.31 (5), p.599-607 [Peer Reviewed Journal]

2014 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2012.43.7384 ;PMID: 23319696

Full text available

5
Randomized Trial of Lapatinib Versus Placebo Added to Paclitaxel in the Treatment of Human Epidermal Growth Factor Receptor 2–Overexpressing Metastatic Breast Cancer
Material Type:
Article
Add to My Research

Randomized Trial of Lapatinib Versus Placebo Added to Paclitaxel in the Treatment of Human Epidermal Growth Factor Receptor 2–Overexpressing Metastatic Breast Cancer

Journal of clinical oncology, 2013-06, Vol.31 (16), p.1947-1953 [Peer Reviewed Journal]

2014 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2011.40.5241 ;PMID: 23509322

Full text available

6
Clinical genotyping and efficacy outcomes: exploratory biomarker data from the phase II ABIGAIL study of first-line bevacizumab plus chemotherapy in non-squamous non-small-cell lung cancer
Material Type:
Article
Add to My Research

Clinical genotyping and efficacy outcomes: exploratory biomarker data from the phase II ABIGAIL study of first-line bevacizumab plus chemotherapy in non-squamous non-small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2014-10, Vol.86 (1), p.67 [Peer Reviewed Journal]

Copyright © 2014 Elsevier Ireland Ltd. All rights reserved. ;EISSN: 1872-8332 ;DOI: 10.1016/j.lungcan.2014.07.019 ;PMID: 25154982

Digital Resources/Online E-Resources

7
Impact of drug-resistant Mycobacterium tuberculosis on treatment outcome of culture-positive cases of tuberculosis in the Archangel Oblast, Russia, in 1999
Material Type:
Article
Add to My Research

Impact of drug-resistant Mycobacterium tuberculosis on treatment outcome of culture-positive cases of tuberculosis in the Archangel Oblast, Russia, in 1999

European journal of clinical microbiology & infectious diseases, 2004-03, Vol.23 (3), p.174-179 [Peer Reviewed Journal]

2004 INIST-CNRS ;Springer-Verlag 2004 ;ISSN: 0934-9723 ;EISSN: 1435-4373 ;DOI: 10.1007/s10096-003-1080-6 ;PMID: 14735405

Full text available

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Searching Remote Databases, Please Wait